Related Experiment Videos
Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
M Oudshoorn1, I I N Doxiadis, P M van den Berg-Loonen
1Europdonor Foundation, Leiden, The Netherlands.
Human Immunology
|March 2, 2002
Summary
Human leukocyte antigen (HLA) incompatibilities significantly correlate with cytotoxic T-lymphocyte precursor (CTLp) frequencies in bone marrow transplants. The CTLp assay may identify permissible mismatches when fully matched donors are unavailable, aiding allograft recognition.
Area of Science:
- Immunogenetics
- Transplantation Immunology
- Molecular Biology
Background:
- Human leukocyte antigen (HLA) incompatibilities pose significant immunological barriers in unrelated donor bone marrow transplants.
- Traditional donor selection involved serological HLA class I and DNA-based HLA class II typing.
- Cytotoxic T-lymphocyte precursor (CTLp) assays have been integral to donor selection at our center.
Purpose of the Study:
- To investigate the correlation between HLA class I incompatibilities and CTLp frequencies in donor-recipient pairs.
- To evaluate the utility of CTLp assays in identifying permissible HLA mismatches for bone marrow transplantation.
Main Methods:
- DNA-based typing for HLA class I (HLA-A, -B, -C) in 211 donor-recipient pairs.
- Assessment of CTLp frequencies against HLA incompatibilities.
- Analysis of HLA amino acid sequences in HLA-C mismatched pairs.
Main Results:
- Significant association (p < 0.001) between HLA class I incompatibilities and high CTLp frequencies.
- Exceptions noted: 14% of matched pairs had high CTLp, and 7% of mismatched pairs had low CTLp.
- HLA-C mismatches showed varied CTLp outcomes; amino acid differences in the peptide-binding groove correlated with high CTLp frequencies.
Conclusions:
- A strong correlation exists between CTLp frequency test results and HLA class I typing, but exceptions warrant further investigation.
- The CTLp assay shows potential as a tool to identify permissible mismatches when no fully matched donor is available.
- Further research is needed to determine the clinical relevance of observed exceptions and their impact on allograft recognition.